Background Inflammation is a hallmark of cancer, and systemic markers of inflammation are
increasingly recognised as negative prognostic factors for clinical outcome. Neutrophil‐to …

Neutrophil–lymphocyte ratio (NLR) is a biomarker of the systemic inflammatory response.
The objective of this systematic scoping review was to examine the literature on NLR and …

Background. Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor
the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the …

Diabetic foot ulcer (DFU) is a well-known complication of diabetes and a significant burden
on the national health systems. The neutrophil/lymphocyte ratio (NLR) and …

Background Neutrophil‐to‐lymphocyte ratio (NLR) is an accessible and widely used
biomarker. NLR may be used as an early marker of poor prognosis in patients with COVID …

Background: The present study aimed to compare the complete blood count (CBC) indices
between COVID-19 patients and the control group, and assess the relationship of these …

OBJECTIVE: To observe the changes in systemic immune-inflammation index (SII),
neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to …

The pathogenesis of diabetic retinopathy is still challenging, with recent evidence proving
the key role of inflammation in the damage of the retinal neurovascular unit. This study aims …

The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are simple
markers of systemic inflammatory responses. It has been previously suggested that they can …

Immune dysregulation is implicated in the pathophysiology of both bipolar and major
depressive disorder, while immune cell ratios (IRCs) have recently been proposed as …